连接研究和临床护理——综合癌症中心。
Bridging research and clinical care - the comprehensive cancer centre.
机构信息
Cancer Research UK Cambridge Centre, UK.
出版信息
Mol Oncol. 2019 Mar;13(3):614-618. doi: 10.1002/1878-0261.12442. Epub 2019 Jan 23.
Abstract
Comprehensive cancer centres (CCCs) are at the heart of the landscape of cancer research, education and care in Europe. They are vital hubs where the historic gaps in the research to clinical care continuum are bridged. CCCs have established hallmarks, but a greater emphasis is needed in Europe to create more effective CCCs using the partnership model of university medical centres and university research departments and institutes. This review will summarise the organisational structures and processes essential for producing quality outcomes for patients and effectiveness in the translational process. The Organisation of European Cancer Institutes and European Academy of Cancer Sciences have established complementary quality accreditations systems to test the clinical and research excellence of CCCs. The EU should have an ambition to create more CCCs based on university hospitals, for each 5-10 million population and in every Member State.
摘要
综合性癌症中心（Comprehensive Cancer Centres，简称 CCC）是欧洲癌症研究、教育和护理领域的核心。它们是连接癌症研究与临床护理之间历史性差距的重要枢纽。CCC 已经建立了一些标志性的模式，但在欧洲，需要更加重视利用大学医疗中心和大学研究部门及机构的伙伴关系模式，来创建更有效的 CCC。本文将总结产生高质量患者治疗效果和转化研究有效性的组织架构和流程。欧洲癌症研究所组织和欧洲癌症科学学院已经建立了互补的质量认证体系，以测试 CCC 的临床和研究卓越性。欧盟应该有雄心在每个成员国，基于每 500 万至 1000 万人口的基础上，建立更多的大学附属医院为基础的 CCC。
相似文献
1
Bridging research and clinical care - the comprehensive cancer centre.连接研究和临床护理——综合癌症中心。
Mol Oncol. 2019 Mar;13(3):614-618. doi: 10.1002/1878-0261.12442. Epub 2019 Jan 23.
2
Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI).迈向质量、全面性与卓越。欧洲癌症研究所组织（OECI）的认证项目。
Tumori. 2008 Mar-Apr;94(2):164-71. doi: 10.1177/030089160809400206.
3
Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.分析欧洲各地综合癌症中心和癌症中心的属性，以确定关键特征。
Mol Oncol. 2021 May;15(5):1277-1288. doi: 10.1002/1878-0261.12950. Epub 2021 Mar 30.
4
Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies.肿瘤学领域卓越的转化研究：通往新型且更有效抗癌疗法的征程。
Mol Oncol. 2016 May;10(5):645-51. doi: 10.1016/j.molonc.2015.12.007. Epub 2015 Dec 23.
5
Managing cancer in the EU: the Organisation of European Cancer Institutes (OECI).欧盟的癌症管理：欧洲癌症研究所组织（OECI）
Eur J Cancer. 2008 Apr;44(6):772-3. doi: 10.1016/j.ejca.2008.01.012. Epub 2008 Mar 11.
6
OECI accreditation of the European Institute of Oncology of Milan: strengths and weaknesses.米兰欧洲肿瘤研究所的OECI认证：优势与不足。
Tumori. 2015;101 Suppl 1:S21-4. doi: 10.5301/tj.5000458. Epub 2015 Dec 30.
7
Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program.欧洲癌症中心的开创性质量评估：欧洲癌症研究所认证与指定计划组织的数据分析
J Oncol Pract. 2014 Sep;10(5):e342-9. doi: 10.1200/JOP.2013.001331. Epub 2014 Aug 12.
8
European Academy of Cancer Sciences-Designation of Comprehensive Cancer Centres of Excellence.欧洲癌症科学学会——卓越综合癌症中心的指定
Eur J Cancer. 2018 Apr;93:138-139. doi: 10.1016/j.ejca.2018.01.003. Epub 2018 Feb 14.
9
European Academy of Cancer Sciences - position paper.欧洲癌症研究学会立场文件。
Mol Oncol. 2018 Nov;12(11):1829-1837. doi: 10.1002/1878-0261.12379. Epub 2018 Sep 21.
10
Cancer Core Europe: A translational research infrastructure for a European mission on cancer.欧洲癌症核心：针对癌症的欧洲任务的转化研究基础设施。
Mol Oncol. 2019 Mar;13(3):521-527. doi: 10.1002/1878-0261.12447. Epub 2019 Feb 2.
引用本文的文献
1
Criteria for establishing a centre of excellence in oncology: a scoping review.建立肿瘤学卓越中心的标准：一项范围综述
BMC Health Serv Res. 2025 Jul 27;25(1):981. doi: 10.1186/s12913-025-13152-3.
2
Bridging the Gap: Embedding Psychosocial Oncology Research into Comprehensive Cancer Care for Children and Young People.弥合差距：将心理社会肿瘤学研究融入儿童和青少年的综合癌症护理中。
Cancers (Basel). 2025 Jun 24;17(13):2123. doi: 10.3390/cancers17132123.
3
Strategies to reduce the cancer burden and improve access to effective and affordable cancer interventions in Europe.欧洲减轻癌症负担并改善获得有效且可负担得起的癌症干预措施的策略。
Mol Oncol. 2025 Jun;19(6):1553-1560. doi: 10.1002/1878-0261.70058. Epub 2025 May 21.
4
Describing the Core Attributes and Impact of Comprehensive Cancer Centers Internationally: A Chronological Scoping Review.描述国际综合癌症中心的核心属性和影响：一项按时间顺序的范围综述。
Cancers (Basel). 2025 Mar 18;17(6):1023. doi: 10.3390/cancers17061023.
5
Understanding the Landscape of Cancer Care in Europe: Evaluating Clinical and Comprehensive Cancer Centers.了解欧洲癌症护理概况：评估临床和综合癌症中心。
Healthcare (Basel). 2024 Nov 22;12(23):2338. doi: 10.3390/healthcare12232338.
6
Bridging the Divide: A Review on the Implementation of Personalized Cancer Medicine.弥合差距：个性化癌症医学实施综述
J Pers Med. 2024 May 24;14(6):561. doi: 10.3390/jpm14060561.
7
Academia and society should join forces to make anti-cancer treatments more affordable.学术界和社会应该联合起来，使抗癌治疗更加负担得起。
Mol Oncol. 2024 Jun;18(6):1351-1354. doi: 10.1002/1878-0261.13651. Epub 2024 Apr 18.
8
Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023.降低癌症治疗、护理和预防方面不平等的策略：由罗马教皇科学院和欧洲癌症学会组织的会议记录，2023 年 2 月 23 日至 24 日，梵蒂冈城。
Mol Oncol. 2024 Feb;18(2):245-279. doi: 10.1002/1878-0261.13575. Epub 2024 Jan 22.
9
Opportunities and Obstacles to the Development of Health Data Warehouses in Hospitals in France: The Recent Experience of Comprehensive Cancer Centers.法国医院健康数据仓库发展的机遇与挑战：综合癌症中心的最新经验。
Int J Environ Res Public Health. 2023 Jan 16;20(2):1645. doi: 10.3390/ijerph20021645.
10
Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.分析欧洲各地综合癌症中心和癌症中心的属性，以确定关键特征。
Mol Oncol. 2021 May;15(5):1277-1288. doi: 10.1002/1878-0261.12950. Epub 2021 Mar 30.
本文引用的文献
1
Future cancer research priorities in the USA: a Lancet Oncology Commission.美国未来癌症研究重点：《柳叶刀·肿瘤学》委员会报告
Lancet Oncol. 2017 Nov;18(11):e653-e706. doi: 10.1016/S1470-2045(17)30698-8. Epub 2017 Oct 31.
2
A mission-oriented approach to cancer in Europe: a joint mission/vision 2030.面向欧洲癌症的使命导向方法：联合使命/愿景 2030。
Mol Oncol. 2017 Dec;11(12):1661-1672. doi: 10.1002/1878-0261.12143. Epub 2017 Nov 9.
3
Integrative clinical genomics of metastatic cancer.转移性癌症的整合临床基因组学
Nature. 2017 Aug 17;548(7667):297-303. doi: 10.1038/nature23306. Epub 2017 Aug 2.
4
Roadmap to a Comprehensive Clinical Data Warehouse for Precision Medicine Applications in Oncology.肿瘤精准医学应用综合临床数据仓库路线图
Cancer Inform. 2017 Mar 2;16:1176935117694349. doi: 10.1177/1176935117694349. eCollection 2017.
5
Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies.肿瘤学领域卓越的转化研究：通往新型且更有效抗癌疗法的征程。
Mol Oncol. 2016 May;10(5):645-51. doi: 10.1016/j.molonc.2015.12.007. Epub 2015 Dec 23.
6
Cell-free circulating tumour DNA as a liquid biopsy in breast cancer.游离循环肿瘤DNA作为乳腺癌的液体活检
Mol Oncol. 2016 Mar;10(3):464-74. doi: 10.1016/j.molonc.2015.12.001. Epub 2015 Dec 17.
7
Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage.在没有癌症分期信息的情况下治疗癌症患者的医院中调整生存结果的风险。
JAMA Oncol. 2015 Dec;1(9):1303-10. doi: 10.1001/jamaoncol.2015.3151.
8
Multidisciplinary cancer care: does it improve outcomes?多学科癌症治疗：它能改善治疗效果吗？
J Surg Oncol. 2014 Oct;110(5):494-9. doi: 10.1002/jso.23700. Epub 2014 Jul 2.
9
Place of multidisciplinary consulting meetings and clinical trials in the management of colorectal cancer in France in 2000.2000年法国结直肠癌管理中多学科咨询会议及临床试验的开展地点。
Gastroenterol Clin Biol. 2007 Mar;31(3):286-91. doi: 10.1016/s0399-8320(07)89375-4.
10
Matrix management: not a structure, a frame of mind.矩阵管理：并非一种结构，而是一种思维模式。
Harv Bus Rev. 1990 Jul-Aug;68(4):138-45.
Zotero 插件